Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 19 studies | 40% ± 15% | |
endothelial cell of lymphatic vessel | 15 studies | 38% ± 10% | |
macrophage | 14 studies | 30% ± 14% | |
myofibroblast cell | 9 studies | 32% ± 14% | |
adipocyte | 9 studies | 52% ± 13% | |
connective tissue cell | 7 studies | 35% ± 15% | |
GABAergic neuron | 6 studies | 40% ± 17% | |
ionocyte | 5 studies | 51% ± 11% | |
retinal bipolar neuron | 5 studies | 42% ± 16% | |
adventitial cell | 5 studies | 43% ± 7% | |
microglial cell | 4 studies | 22% ± 3% | |
plasma cell | 4 studies | 27% ± 6% | |
hepatocyte | 4 studies | 47% ± 22% | |
mononuclear phagocyte | 3 studies | 27% ± 14% | |
smooth muscle cell | 3 studies | 39% ± 24% | |
myeloid cell | 3 studies | 23% ± 11% | |
OFF-bipolar cell | 3 studies | 32% ± 6% | |
ON-bipolar cell | 3 studies | 36% ± 8% | |
rod bipolar cell | 3 studies | 53% ± 6% | |
interneuron | 3 studies | 45% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
uterus | 4 studies | 23% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 1178.98 | 242 / 245 | 81% | 4.78 | 406 / 502 |
liver | 99% | 731.75 | 224 / 226 | 48% | 1.93 | 193 / 406 |
breast | 100% | 1319.43 | 458 / 459 | 36% | 0.84 | 400 / 1118 |
ovary | 66% | 293.96 | 119 / 180 | 63% | 2.28 | 271 / 430 |
uterus | 99% | 819.57 | 168 / 170 | 22% | 1.65 | 103 / 459 |
thymus | 97% | 934.19 | 634 / 653 | 18% | 0.53 | 108 / 605 |
lung | 80% | 415.68 | 464 / 578 | 26% | 0.77 | 303 / 1155 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.14 | 1 / 1 |
adipose | 100% | 1260.94 | 1200 / 1204 | 0% | 0 | 0 / 0 |
bladder | 76% | 525.71 | 16 / 21 | 14% | 0.45 | 72 / 504 |
esophagus | 70% | 408.10 | 1008 / 1445 | 10% | 0.33 | 19 / 183 |
blood vessel | 78% | 619.91 | 1039 / 1335 | 0% | 0 | 0 / 0 |
intestine | 60% | 197.83 | 578 / 966 | 9% | 0.23 | 48 / 527 |
adrenal gland | 64% | 160.85 | 165 / 258 | 3% | 0.07 | 8 / 230 |
stomach | 43% | 217.73 | 154 / 359 | 21% | 0.83 | 59 / 286 |
heart | 61% | 278.71 | 528 / 861 | 0% | 0 | 0 / 0 |
pancreas | 26% | 57.69 | 86 / 328 | 32% | 1.42 | 57 / 178 |
muscle | 51% | 143.44 | 410 / 803 | 0% | 0 | 0 / 0 |
skin | 31% | 86.30 | 564 / 1809 | 14% | 0.31 | 65 / 472 |
spleen | 37% | 56.97 | 90 / 241 | 0% | 0 | 0 / 0 |
kidney | 20% | 87.84 | 18 / 89 | 10% | 0.28 | 94 / 901 |
peripheral blood | 18% | 122.51 | 170 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.14 | 3 / 29 |
brain | 1% | 0.96 | 16 / 2642 | 3% | 0.04 | 18 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_2000679 | Biological process | positive regulation of transcription regulatory region DNA binding |
GO_0042104 | Biological process | positive regulation of activated T cell proliferation |
GO_0010468 | Biological process | regulation of gene expression |
GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
GO_0008283 | Biological process | cell population proliferation |
GO_0061051 | Biological process | positive regulation of cell growth involved in cardiac muscle cell development |
GO_0048009 | Biological process | insulin-like growth factor receptor signaling pathway |
GO_0150079 | Biological process | negative regulation of neuroinflammatory response |
GO_0001775 | Biological process | cell activation |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050821 | Biological process | protein stabilization |
GO_0046579 | Biological process | positive regulation of Ras protein signal transduction |
GO_0001501 | Biological process | skeletal system development |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0010560 | Biological process | positive regulation of glycoprotein biosynthetic process |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_1904707 | Biological process | positive regulation of vascular associated smooth muscle cell proliferation |
GO_0009408 | Biological process | response to heat |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0007165 | Biological process | signal transduction |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0014911 | Biological process | positive regulation of smooth muscle cell migration |
GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
GO_0042060 | Biological process | wound healing |
GO_0050679 | Biological process | positive regulation of epithelial cell proliferation |
GO_0051450 | Biological process | myoblast proliferation |
GO_0043568 | Biological process | positive regulation of insulin-like growth factor receptor signaling pathway |
GO_0045821 | Biological process | positive regulation of glycolytic process |
GO_0014834 | Biological process | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0032148 | Biological process | activation of protein kinase B activity |
GO_0009441 | Biological process | glycolate metabolic process |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_1902430 | Biological process | negative regulation of amyloid-beta formation |
GO_0070886 | Biological process | positive regulation of calcineurin-NFAT signaling cascade |
GO_0090201 | Biological process | negative regulation of release of cytochrome c from mitochondria |
GO_0034392 | Biological process | negative regulation of smooth muscle cell apoptotic process |
GO_0050714 | Biological process | positive regulation of protein secretion |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045445 | Biological process | myoblast differentiation |
GO_0007517 | Biological process | muscle organ development |
GO_0043388 | Biological process | positive regulation of DNA binding |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0060283 | Biological process | negative regulation of oocyte development |
GO_1905460 | Biological process | negative regulation of vascular associated smooth muscle cell apoptotic process |
GO_1904646 | Biological process | cellular response to amyloid-beta |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0001837 | Biological process | epithelial to mesenchymal transition |
GO_0030166 | Biological process | proteoglycan biosynthetic process |
GO_0014904 | Biological process | myotube cell development |
GO_0046326 | Biological process | positive regulation of glucose import |
GO_0010613 | Biological process | positive regulation of cardiac muscle hypertrophy |
GO_0001932 | Biological process | regulation of protein phosphorylation |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0045725 | Biological process | positive regulation of glycogen biosynthetic process |
GO_1904075 | Biological process | positive regulation of trophectodermal cell proliferation |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_0035630 | Biological process | bone mineralization involved in bone maturation |
GO_0014896 | Biological process | muscle hypertrophy |
GO_0045840 | Biological process | positive regulation of mitotic nuclear division |
GO_0070382 | Cellular component | exocytic vesicle |
GO_0005576 | Cellular component | extracellular region |
GO_0042567 | Cellular component | insulin-like growth factor ternary complex |
GO_0031093 | Cellular component | platelet alpha granule lumen |
GO_0016942 | Cellular component | insulin-like growth factor binding protein complex |
GO_0005615 | Cellular component | extracellular space |
GO_0035867 | Cellular component | alphav-beta3 integrin-IGF-1-IGF1R complex |
GO_0005179 | Molecular function | hormone activity |
GO_0005515 | Molecular function | protein binding |
GO_0005158 | Molecular function | insulin receptor binding |
GO_0005159 | Molecular function | insulin-like growth factor receptor binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0005178 | Molecular function | integrin binding |
Gene name | IGF1 |
Protein name | Alternative protein IGF1 Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C) Insulin-like growth factor I Insulin-like growth factor-I |
Synonyms | hCG_21873 IBP1 |
Description | FUNCTION: The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation . Ca(2+)-dependent exocytosis of IGF1 is required for sensory perception of smell in the olfactory bulb (By similarity). Acts as a ligand for IGF1R. Binds to the alpha subunit of IGF1R, leading to the activation of the intrinsic tyrosine kinase activity which autophosphorylates tyrosine residues in the beta subunit thus initiating a cascade of down-stream signaling events leading to activation of the PI3K-AKT/PKB and the Ras-MAPK pathways. Binds to integrins ITGAV:ITGB3 and ITGA6:ITGB4. Its binding to integrins and subsequent ternary complex formation with integrins and IGFR1 are essential for IGF1 signaling. Induces the phosphorylation and activation of IGFR1, MAPK3/ERK1, MAPK1/ERK2 and AKT1 . As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via promotion of STUB1/CHIP-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). . |
Accessions | ENST00000337514.11 [P05019-2] ENST00000307046.8 [P05019-1] L8E8N9 Q9NP10 Q6LD41 L8EC78 ENST00000392904.5 [P05019-4] ENST00000424202.6 [P05019-3] ENST00000644491.1 [P05019-2] Q5U743 P05019 ENST00000392905.7 [P05019-4] |